| Balu, Mihaela |
University Of California-Irvine
United States |
Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma |
5R01CA259019-02 |
PAR-20-155 (R01 Clinical Trial Optional) |
Richard Mazurchuk, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
|
Rachel Altshuler, Ph.D. |
| Maitra, Anirban |
University Of Tx Md Anderson Can Ctr
United States |
Clinical Validation Center for Early Detection of Pancreatic Cancer |
5U01CA200468-07 |
|
Matthew Young, Ph.D. |
| Hu, Shuiying |
Ohio State University
United States |
Prevention of paclitaxel-induced peripheral neuropathy with nilotinib |
5R01CA238946-05 |
|
Rachel Altshuler, Ph.D. |
| Pyter, Leah M |
Ohio State University
United States |
Chemotherapy-induced circadian master clock disruptions and fatigue |
3R01CA270372-02S1 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Marge Good, R.N., M.P.H., O.C.N. |
| Eibl, Guido Erwin Michael |
University Of California Los Angeles
United States |
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma |
5P01CA236585-05 |
PAR-18-290 (P01 Clinical Trial Optional) |
Sharon Ross, Ph.D., M.P.H. |
| Rosser, Charles J |
Cedars-Sinai Medical Center
United States |
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology |
5R01CA277810-02 |
|
|
| Arcaro, Kathleen Frances |
University Of Massachusetts Amherst
United States |
Fruit and vegetable intervention in lactating women to reduce breast cancer risk: effects on breast cell DNA methylation, breast inflammation, and weight |
5R01CA230478-05 |
|
Sharon Ross, Ph.D., M.P.H. |
| Paulovich, Amanda G |
Fred Hutchinson Cancer Center
United States |
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment |
1U2CCA271873-01A1 |
|
Sidney Fu, M.D. |
| Brenner, Dean E. |
University Of Michigan At Ann Arbor
United States |
Early Phase Clinical Cancer Prevention Consortium |
5UG1CA242632-04 |
RFA-CA-19-031 (UG1 Clinical Trial Required) |
Donald Johnsey |